Filter by content type
Filter by year
Vaccinex, Inc. Announces the First Patient Treated in a Phase Ib/II Combination Study with Anti-Semaphorin 4D Antibody, VX15/2503, and Avelumab in Non-Small Cell Lung Cancer Patients (CLASSICAL – Lung)
October 26, 2017 - … 4D Antibody, VX15/2503, and Avelumab in Non-Small Cell Lung Cancer Patients (CLASSICAL – Lung) … Vaccinex, Inc. Announces the First … and Avelumab in Non-Small Cell Lung Cancer Patients (CLASSICAL – Lung) Vaccinex, Inc. Announces the First Patient …